Profile
Full Name
Artiva Biotherapeutics, Inc.Ticker Symbol
ARTVExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
Indexes
Not includedWebsite
http://www.artivabio.comEmployees
89Key Details
Price
$2.54
Market Cap
$61.88M(Small cap)
Last Dividend
-
TTM Dividend Yield
-
Annual Revenue
$251.00K(-99.25% YoY)
Annual EPS
-$5.81(-388.40% YoY)
PE Ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Artiva Biotherapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 26, 25 HC Wainwright & Co.
BuyMar 25, 25 Wedbush
OutperformMar 25, 25 Needham
BuyMar 25, 25 Cantor Fitzgerald
OverweightDec 30, 24 HC Wainwright & Co.
BuyNov 13, 24 Needham
BuyAug 30, 24 Needham
BuyAug 13, 24 Wedbush
OutperformAug 13, 24 TD Cowen
BuyAug 13, 24 Needham
BuyInstitutional Ownership
- What is the ticker symbol for Artiva Biotherapeutics?
- Does Artiva Biotherapeutics pay dividends?
- What sector is Artiva Biotherapeutics in?
- What industry is Artiva Biotherapeutics in?
- What country is Artiva Biotherapeutics based in?
- Is Artiva Biotherapeutics in the S&P 500?
- Is Artiva Biotherapeutics in the NASDAQ 100?
- Is Artiva Biotherapeutics in the Dow Jones?
- When was Artiva Biotherapeutics's last earnings report?
- When does Artiva Biotherapeutics report earnings?
- Should I buy Artiva Biotherapeutics stock now?
What is the ticker symbol for Artiva Biotherapeutics?
The ticker symbol for Artiva Biotherapeutics is NASDAQ:ARTV
Does Artiva Biotherapeutics pay dividends?
No, Artiva Biotherapeutics does not pay dividends
What sector is Artiva Biotherapeutics in?
Artiva Biotherapeutics is in the Healthcare sector
What industry is Artiva Biotherapeutics in?
Artiva Biotherapeutics is in the Biotechnology industry
What country is Artiva Biotherapeutics based in?
Artiva Biotherapeutics is headquartered in United States
Is Artiva Biotherapeutics in the S&P 500?
No, Artiva Biotherapeutics is not included in the S&P 500 index
Is Artiva Biotherapeutics in the NASDAQ 100?
No, Artiva Biotherapeutics is not included in the NASDAQ 100 index
Is Artiva Biotherapeutics in the Dow Jones?
No, Artiva Biotherapeutics is not included in the Dow Jones index
When was Artiva Biotherapeutics's last earnings report?
Artiva Biotherapeutics's most recent earnings report was on Mar 24, 2025
When does Artiva Biotherapeutics report earnings?
The next expected earnings date for Artiva Biotherapeutics is May 30, 2025
Should I buy Artiva Biotherapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions